Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu
Trial record 53 of 149 for:    colon cancer AND Capecitabine AND colon cancer

Capecitabine (Xeloda) and Radiation for Patients With Rectosigmoid Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00216424
Recruitment Status : Terminated (lack of accrual)
First Posted : September 22, 2005
Last Update Posted : November 12, 2007
Hoffmann-La Roche
Information provided by:
James A. Haley Veterans Administration Hospital

No Study Results Posted on for this Study
Recruitment Status : Terminated
Primary Completion Date : No date given
Actual Study Completion Date : January 2007